{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:26:25Z","timestamp":1695497185449},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T00:00:00Z","timestamp":1430006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00228-015-1836-9","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T00:40:49Z","timestamp":1429922449000},"page":"723-732","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analgesic use before and after oral anticoagulant initiation\u2014a population-based study in Finland"],"prefix":"10.1007","volume":"71","author":[{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arja","family":"Helin-Salmivaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risto","family":"Huupponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rikala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl M.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit Jaana","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,26]]},"reference":[{"key":"1836_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(93)90285-W","volume":"95","author":"CS Landefeld","year":"1993","unstructured":"Landefeld CS, Beyth RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 95:315\u2013328","journal-title":"Am J Med"},{"key":"1836_CR2","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.ejim.2014.02.005","volume":"25","author":"S Antoniazzi","year":"2014","unstructured":"Antoniazzi S, Berda\u00ef D, Conti V (2014) Risk of major bleeding and the standard doses of dabigatran. Eur J Intern Med 25:e73\u2013e75","journal-title":"Eur J Intern Med"},{"key":"1836_CR3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/STROKEAHA.111.615260","volume":"42","author":"J Huhtakangas","year":"2011","unstructured":"Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M (2011) Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke 42:2431\u20132435","journal-title":"Stroke"},{"key":"1836_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00228-012-1386-3","volume":"69","author":"FJ Abajo de","year":"2013","unstructured":"de Abajo FJ, Gil MJ, Bryant V, Timoner J, Oliva B, Garc\u00eda-Rodr\u00edguez LA (2013) Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case\u2013control study in a new general practice database. Eur J Clin Pharmacol 69:691\u2013701","journal-title":"Eur J Clin Pharmacol"},{"key":"1836_CR5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07853890903186168","volume":"41","author":"M Hauta-Aho","year":"2009","unstructured":"Hauta-Aho M, Tirkkonen T, Vahlberg T, Laine K (2009) The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Ann Med 41:619\u2013628","journal-title":"Ann Med"},{"key":"1836_CR6","doi-asserted-by":"crossref","first-page":"e21447","DOI":"10.1371\/journal.pone.0021447","volume":"6","author":"H Schelleman","year":"2011","unstructured":"Schelleman H, Brensinger CM, Bilker WB, Hennessy S (2011) Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case\u2013control study. PLoS One 6:e21447","journal-title":"PLoS One"},{"key":"1836_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2710.2007.00891.x","volume":"33","author":"JJ Gagne","year":"2008","unstructured":"Gagne JJ, Maio V, Rabinowitz C (2008) Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 33:141\u2013151","journal-title":"J Clin Pharm Ther"},{"key":"1836_CR8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2146\/ajhp040567","volume":"62","author":"D Malone","year":"2005","unstructured":"Malone D, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB (2005) Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 62:1983\u20131991","journal-title":"Am J Health Syst Pharm"},{"key":"1836_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2125.2010.03694.x","volume":"70","author":"EE Roughead","year":"2010","unstructured":"Roughead EE, Kalisch LM, Barratt JD, Gilbert AL (2010) Prevalence of potentially hazardous drug interactions amongst Australian veterans. Br J Clin Pharmacol 70:252\u2013257","journal-title":"Br J Clin Pharmacol"},{"key":"1836_CR10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1345\/aph.1M284","volume":"43","author":"TG Cheetham","year":"2009","unstructured":"Cheetham TG, Levy G, Niu F, Bixler F (2009) Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin. Ann Pharmacother 43:1765\u20131773","journal-title":"Ann Pharmacother"},{"key":"1836_CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00228-012-1363-x","volume":"69","author":"A Potteg\u00e5rd","year":"2013","unstructured":"Potteg\u00e5rd A, Meegaard PM, Holck LH, Christensen RD, Madsen H, Hallas J (2013) Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case\u2013control study. Eur J Clin Pharmacol 69:641\u2013646","journal-title":"Eur J Clin Pharmacol"},{"key":"1836_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00228-010-0975-2","volume":"67","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Bal-dit-Sollier C, Drouet L, Simoneau G, Alvarez J-C, Pruvot S, Aubourg R, Berge N, Bergmann J-F, Mouly S, Mah\u00e9 I (2011) Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol 67:309\u2013314","journal-title":"Eur J Clin Pharmacol"},{"key":"1836_CR13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","volume":"479","author":"EM Hylek","year":"1998","unstructured":"Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 479:657\u2013662","journal-title":"JAMA"},{"key":"1836_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/joim.12138","volume":"275","author":"S Schulman","year":"2014","unstructured":"Schulman S (2014) Advantages and limitations of the new anticoagulants. J Intern Med 275:1\u201311","journal-title":"J Intern Med"},{"key":"1836_CR15","doi-asserted-by":"crossref","first-page":"g4747","DOI":"10.1136\/bmj.g4747","volume":"349","author":"D Cohen","year":"2014","unstructured":"Cohen D (2014) Concerns over data in key dabigatran trial. Br Med J 349:g4747","journal-title":"Br Med J"},{"key":"1836_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11239-014-1125-y","volume":"39","author":"M Samo\u0161","year":"2015","unstructured":"Samo\u0161 M, Stan\u010diakov\u00e1 L, Ivankov\u00e1 J, Sta\u0161ko J, Kov\u00e1\u0159 F, Dobrotov\u00e1 M, Galajda P, Kubisz P, Mok\u00e1\u0148 M (2015) Monitoring of dabigatran therapy using Hemoclot Thrombin Inhibitor assay in patients with atrial fibrillation. J Thromb Thrombolysis 39:95\u2013100","journal-title":"J Thromb Thrombolysis"},{"key":"1836_CR17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/bcp.12366","volume":"78","author":"PK Chin","year":"2014","unstructured":"Chin PK, Patterson DM, Zhang M, Jensen BP, Wright DF, Barclay ML, Begg EJ (2014) Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran. Br J Clin Pharmacol 78:630\u2013638","journal-title":"Br J Clin Pharmacol"},{"key":"1836_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/europace\/euu225","volume":"17","author":"JB Olesen","year":"2015","unstructured":"Olesen JB, S\u00f8rensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, K\u00f8ber L, Gislason GH, Torp-Pedersen C, Fosb\u00f8l EL (2015) Non-vitamin K antagonist oral anticoagulation agents in anticoagulant na\u00efve atrial fibrillation patients: Danish nationwide descriptive data 2011\u20132013. Europace 17:187\u2013193","journal-title":"Europace"},{"key":"1836_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/clc.22204","volume":"37","author":"I Savelieva","year":"2014","unstructured":"Savelieva I, Camm AJ (2014) Practical considerations for using novel oral anticoagulants in patients with atrial fibrillation. Clin Cardiol 37:32\u201347","journal-title":"Clin Cardiol"},{"key":"1836_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/157488412800958695","volume":"7","author":"S Deftereos","year":"2012","unstructured":"Deftereos S, Anatoliotakis N, Giannopoulos G, Kaoukis A, Mavri M, Pyrgakis V, Stefanadis C (2012) Novel direct factor IIa and Xa inhibitors: mechanisms of action and preclinical studies. Curr Clin Pharmacol 7:149\u2013165","journal-title":"Curr Clin Pharmacol"},{"key":"1836_CR21","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1177\/1060028013504741","volume":"47","author":"T Hellwig","year":"2013","unstructured":"Hellwig T, Gulseth M (2013) Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation? Ann Pharmacother 47:1478\u20131487","journal-title":"Ann Pharmacother"},{"key":"1836_CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","volume":"63","author":"PA Reilly","year":"2014","unstructured":"Reilly PA, Lehr T, Haertter S, Connolly SJ, Yusuf S, Eikelboom JW, Ezekowitz MD, Nehmiz G, Wang S, Wallentin L, Investigators RE-LY (2014) The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol 63:321\u2013328","journal-title":"J Am Coll Cardiol"},{"key":"1836_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bcp.12364","volume":"78","author":"PK Chin","year":"2014","unstructured":"Chin PK, Wright DF, Patterson DM, Doogue MP, Begg EJ (2014) A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time. Br J Clin Pharmacol 78:599\u2013609","journal-title":"Br J Clin Pharmacol"},{"key":"1836_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40256-013-0061-0","volume":"13","author":"Y Wang","year":"2014","unstructured":"Wang Y, Bajorek B (2014) New oral anticoagulants in practice: pharmacological and practical considerations. Am J Cardiovasc Drugs 13:175\u2013189","journal-title":"Am J Cardiovasc Drugs"},{"key":"1836_CR25","doi-asserted-by":"crossref","unstructured":"Masotti L, Lorenzini G, Seravalle C, Panigada G, Landini G, Cappelli R, Schulman S (2014) Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report. J Thromb Thrombolysis. doi: 10.1007\/s11239-014-1112-3","DOI":"10.1007\/s11239-014-1112-3"},{"key":"1836_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/14779072.2015.987126","volume":"13","author":"S Vanden Daelen","year":"2015","unstructured":"Vanden Daelen S, Peetermans M, Vanassche T, Verhamme P, Vandermeulen E (2015) Monitoring and reversal strategies for new oral anticoagulants. Expert Rev Cardiovasc Ther 13:95\u2013103","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1836_CR27","doi-asserted-by":"crossref","first-page":"e97388","DOI":"10.1371\/journal.pone.0097388","volume":"9","author":"JD Lindh","year":"2014","unstructured":"Lindh JD, Andersson ML, Mannheimer B (2014) Adherence to guidelines for avoiding drug interactions associated with warfarin\u2014a nationwide Swedish register study. PLoS One 9:e97388","journal-title":"PLoS One"},{"key":"1836_CR28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00228-014-1697-7","volume":"70","author":"K Jobski","year":"2014","unstructured":"Jobski K, Enders D, Amann U, Suzart K, Wallander MA, Schink T, Garbe E (2014) Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital. Eur J Clin Pharmacol 70:975\u2013981","journal-title":"Eur J Clin Pharmacol"},{"key":"1836_CR29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86\u201394","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1836_CR30","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2015) The anatomical therapeutic chemical classification system. Oslo: WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. http:\/\/www.whocc.no\/atcddd\/ . Accessed Jan 12, 2015"},{"key":"1836_CR31","unstructured":"Social Insurance Institution of Finland (2014) Limited basic reimbursability for certain medicines. Social Insurance Institution of Finland. http:\/\/www.kela.fi\/laakkeet-ja-laakekorvaukset_rajoitetun-korvattavuuden-alkamisajat . Accessed Oct 10, 2014"},{"key":"1836_CR32","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s40265-014-0278-5","volume":"74","author":"T Trujillo","year":"2014","unstructured":"Trujillo T, Dobesh PP (2014) Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs 74:1587\u20131603","journal-title":"Drugs"},{"key":"1836_CR33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/02813432.2010.514138","volume":"28","author":"I Virjo","year":"2010","unstructured":"Virjo I, M\u00e4kel\u00e4 K, Aho J, Kalliola P, Kurunm\u00e4ki H, Uusitalo L, Valli M, Ylinen S (2010) Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland. Scand J Prim Health Care 28:237\u2013241","journal-title":"Scand J Prim Health Care"},{"key":"1836_CR34","volume-title":"Finnish statistics on medicines 2012","author":"Finnish Medicines Agency Fimea, Social Insurance Institution of Finland","year":"2013","unstructured":"Finnish Medicines Agency Fimea, Social Insurance Institution of Finland (2013) Finnish statistics on medicines 2012. Fimea and Social Insurance Institution of Finland, Helsinki"},{"key":"1836_CR35","doi-asserted-by":"crossref","unstructured":"Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology (2009) Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 104:728\u2013738","DOI":"10.1038\/ajg.2009.115"},{"key":"1836_CR36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.thromres.2011.12.005","volume":"130","author":"BI Eriksson","year":"2012","unstructured":"Eriksson BI, Rosencher N, Friedman RJ, Homering M, Dahl OE (2012) Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty. Thromb Res 130:147\u2013151","journal-title":"Thromb Res"},{"key":"1836_CR37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamainternmed.2014.946","volume":"174","author":"BL Davidson","year":"2014","unstructured":"Davidson BL, Verheijen S, Lensing AW, Gebel M, Brighton TA, Lyons RM, Rehm J, Prins MH (2014) Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med 174:947\u2013953","journal-title":"JAMA Intern Med"},{"key":"1836_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1160\/TH11-08-0589","volume":"108","author":"RJ Friedman","year":"2012","unstructured":"Friedman RJ, Kurth A, Clemens A, Noack H, Eriksson B, Caprini JA (2012) Dabigatran etexilate and concomitant use of non-steroidal antiinflammatory. Thromb Haemost 108:183\u2013190","journal-title":"Thromb Haemost"},{"key":"1836_CR39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2125.2006.02776.x","volume":"63","author":"D Kubitza","year":"2007","unstructured":"Kubitza D, Becka M, Mueck W, Zuehlsdorf M (2007) Rivaroxaban (BAY 59\u20137939)\u2014an oral, direct Factor Xa inhibitor\u2014has no clinically relevant interaction with naproxen. Br J Clin Pharmacol 63:469\u2013476","journal-title":"Br J Clin Pharmacol"},{"key":"1836_CR40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/17474086.2013.853430","volume":"6","author":"S Rachidi","year":"2013","unstructured":"Rachidi S, Aldin ES, Greenberg C, Sachs B, Streiff M, Zeidan AM (2013) The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery. Expert Rev Hematol 6:677\u2013695","journal-title":"Expert Rev Hematol"},{"key":"1836_CR41","volume-title":"Hip fracture: current care guideline","author":"Working group appointed by the Finnish Medical Society Duodecim and the Finnish Orthopaedic Association","year":"2011","unstructured":"Working group appointed by the Finnish Medical Society Duodecim and the Finnish Orthopaedic Association (2011) Hip fracture: current care guideline. The Finnish Medical Society Duodecim, Helsinki"},{"key":"1836_CR42","volume-title":"Osteoarthritis: current care guideline.","author":"Working group appointed by the Finnish Medical Society Duodecim and the Finnish Orthopaedic Association","year":"2012","unstructured":"Working group appointed by the Finnish Medical Society Duodecim and the Finnish Orthopaedic Association (2012) Osteoarthritis: current care guideline. The Finnish Medical Society Duodecim, Helsinki"},{"key":"1836_CR43","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.3399\/bjgp14X677815","volume":"64","author":"AR Koffeman","year":"2014","unstructured":"Koffeman AR, Valkhoff VE, Celik S, W\u2019t Jong G, Sturkenboom MC, Bindels PJ, van der Lei J, Luijsterburg PA, Bierma-Zeinstra SM (2014) High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract 64:e191\u2013e198","journal-title":"Br J Gen Pract"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1836-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1836-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:49:12Z","timestamp":1558702152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1836-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1836-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,26]]}}}